Acute parvovirus B19 infection associated with fulminant hepatitis of favourable prognosis in young children

Lancet

Volumn 352, Issue 9142, 1998, Pages 1739-1741

  Sokal, Etienne Marc ^a   Melchior, Marie ^a   Cornu, Chantal ^a   Vandenbroucke, Anne Thérèse ^a   Buts, Jean Paul ^a   Cohen, Bernard J ^b   Burtonboy, Guy ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; IMMUNOGLOBULIN M; VIRUS ANTIBODY;

ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; ERYTHEMA INFECTIOSUM; HEPATITIS; HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SERUM; VIRUS GENOME;

EID: 0032576405     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)06165-0     Document Type: Article

References (17)

1. 1 Durand P, Debray D, DeVictor D. Les hépatites fulminantes de l'enfant. La Presse Méd 1996; 25: 1501-06.
2. 2 Cames B, Rahier J, Burtonboy G, et al. Acute adenovirus hepatitis in liver transplant recipients. J Pediatr 1992; 120: 33-37.
3. 3 Langnas A, Markin R, Cattral M, Naides S. Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anemia. Hepatology 1995; 22: 1661-65.
4. 4 Yoto Y, Kudoo T, Haseyama K, Suzuki N, Chiba S. Human parvovirus B19 infection associated with acute hepatitis. Lancet 1996; 347: 868-69.
5. 5 Yoto Y, Kudoh T, Asanuma H, et al. Transient disturbance of consciousness and hepatic dysfunction associated with human parvovirus B19 infection. Lancet 1994; 344: 624-25.
6. 6 Young N. Hematologic and hematopoietic consequences of B19 parvovirus infection. Semin Hematol 1988; 2: 159-72.
7. 7 Cohen B. Parvovirus B19: an expanding spectrum of disease. BMJ 1995; 311: 1549-52.
8. 8 Söderlund M, von Essen R, Haapasaari J, Kiistala U, Kiviluoto O, Hedman K. Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy. Lancet 1997; 349: 1063-65.
9. 9 Foto F, Saag KG, Scharosch LL, Howard EJ, Naides SJ. Parvovirus B19-specific DNA in bone marrow from arthropathy patients: evidence for B19 virus persistence. J Infect Dis 1993; 167: 744-48.
10. 10 DeVictor D, Desplanques L, Debray D, et al. Emergency liver transplantation for fulminant liver failure in infants and children. Hepatology 1992; 16: 1156-62.
11. 11 Lee WM. Acute liver failure. N Engl J Med 1993; 329: 1862-72.
12. 12 Boom R, Sol CJ, Salimans MM, Larsen CL, Wertheim-VanDillen PM, Van der Noorda J. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990; 28: 495-503.
13. 13 Clewley JP. PCR detection of parvovirus B19. In: Persing DH, Smith TF, Tenover FC, White TJ, eds. Diagnostic molecular biology: principles and applications. Washington: American Society for Microbiology, 1993: 367-73.
14. 14 Mori J, Field AM, Clewley JP, Cohen BJ. Dot blot hybridization assay of B19 virus DNA in clinical specimen. J Clin Microbiol 1989; 27: 459-64.
15. 15 Hicks KE, Beard S, Cohen BJ, Clewley JP. A simple and sensitive DNA hybridization assay used for the routine diagnosis of human parvovirus B19 infection. J Clin Microbiol 1995; 33: 2473-75.
16. 16 Debray D, Cullufi P, DeVictor D, Fabre M, Bernard O. Liver failure in children with hepatitis A. Hepatology 1997; 26: 1018-22.
17. 17 Hillings J, Panum Jensen I, Tom-Petersen L. Parvovirus B19 and acute hepatitis in adults. Lancet 1998; 351: 955-56.